Literature DB >> 25779993

To screen or not to screen: that is not (yet) the question.

Delphine S Tuot1, Carmen A Peralta2.   

Abstract

Keywords:  CKD; screening; socioeconomic status

Mesh：

Year:  2015        PMID： 25779993      PMCID： PMC4386248          DOI： 10.2215/CJN.02150215

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  22 in total

Review 1.  GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.

Authors:  Andrew S Levey; Lesley A Inker; Kunihiro Matsushita; Tom Greene; Kerry Willis; Edmund Lewis; Dick de Zeeuw; Alfred K Cheung; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-10-16       Impact factor: 8.860

2.  Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-10-16       Impact factor: 25.391

3.  Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Authors:  Carmen A Peralta; Michael G Shlipak; Suzanne Judd; Mary Cushman; William McClellan; Neil A Zakai; Monika M Safford; Xiao Zhang; Paul Muntner; David Warnock
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

4.  Poverty, race, and CKD in a racially and socioeconomically diverse urban population.

Authors:  Deidra C Crews; Raquel F Charles; Michele K Evans; Alan B Zonderman; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2010-03-06       Impact factor: 8.860

5.  Albumin to creatinine ratio: a screening test with limitations.

Authors:  Christine A Houlihan; Con Tsalamandris; Aysel Akdeniz; George Jerums
Journal:  Am J Kidney Dis       Date:  2002-06       Impact factor: 8.860

Review 6.  Albuminuria: is it time to screen the general population?

Authors:  Deidra C Crews; L Ebony Boulware; Ron T Gansevoort; Bernard G Jaar
Journal:  Adv Chronic Kidney Dis       Date:  2011-07       Impact factor: 3.620

7.  Added value of screening for CKD among the elderly or persons with low socioeconomic status.

Authors:  Priya Vart; Sjimen A Reijneveld; Ute Bültmann; Ronald T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2015-03-16       Impact factor: 8.237

8.  Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration.

Authors:  Ronald D Perrone; Stephen Joel Coons; Kerri Cavanaugh; Fred Finkelstein; Klemens B Meyer
Journal:  Am J Kidney Dis       Date:  2013-08-26       Impact factor: 8.860

Review 9.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.

Authors:  Lesley A Inker; Brad C Astor; Chester H Fox; Tamara Isakova; James P Lash; Carmen A Peralta; Manjula Kurella Tamura; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2014-03-16       Impact factor: 8.860

10.  Population based screening for chronic kidney disease: cost effectiveness study.

Authors:  Braden Manns; Brenda Hemmelgarn; Marcello Tonelli; Flora Au; T Carter Chiasson; James Dong; Scott Klarenbach
Journal:  BMJ       Date:  2010-11-08
View more
  2 in total

1.  Risk Factors Associated With Abnormal Urinalysis in Children.

Authors:  Xuhui Zhong; Jie Ding; Zheng Wang; Yan Gao; Yubin Wu; Ying Shen; Hongmei Song; Zhengyan Zhao; Xinxin Chen; Puhong Zhang; Guobin Xu; Chen Yao; Hui Zhang; Fu Zhong; Ying Tang; Hui Wang; Wei Wang; Wenhao Li; Wanxia Zhang; Sainan Zhu; Meixia Shang
Journal:  Front Pediatr       Date:  2021-03-25       Impact factor: 3.418

2.  A population health dietary intervention for African American adults with chronic kidney disease: The Fruit and Veggies for Kidney Health randomized study.

Authors:  Donald E Wesson; Heather Kitzman; Aisha Montgomery; Abdullah Mamun; Winfred Parnell; Brian Vilayvanh; Kristen M Tecson; Patricia Allison
Journal:  Contemp Clin Trials Commun       Date:  2020-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.